PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump Inhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non‐hodgkin Lymphoma to compare the difference in efficacy.
Epistemonikos ID: a8f5b76e8c43a9df6c53d5264eb58fb098ef85a7
First added on: May 21, 2024